From: Long-term risk of mortality for acute kidney injury in HIV-infected patients: a cohort analysis
Variable | No AKI | AKI | P-value |
---|---|---|---|
(N=369) | (N=64) | ||
Age (years) | 41.3 (11.7) | 42 (10.4) | 0.647 |
Gender (Male) | 248 (67.2%) | 42 (65.6%) | 0.804 |
Race (Caucasian) | 267 (72.3%) | 45 (70.3%) | 0.736 |
Comorbidity | |||
Diabetes mellitus | 21 (5.7%) | 3 (4.7%) | 0.746 |
Hypertension | 36 (9.8%) | 12 (18.8%) | 0.034 |
CVD | 19 (5.1%) | 3 (4.7%) | 0.877 |
CKD | 7 (1.9%) | 6 (9.4%) | 0.001 |
Chronic lung disease | 11 (2.9%) | 0 (0%) | 0.162 |
Cirrhosis | 32 (8.7%) | 9 (14.1%) | 0.174 |
HCV coinfection | 124 (33.6%) | 20 (31.3%) | 0.712 |
HBV coinfection | 25 (6.8%) | 8 (12.5%) | 0.111 |
Cancer | 30 (8.1%) | 6 (9.4%) | 0.739 |
HIV-related characteristics | |||
Type of HIV (HIV-1) | 349 (94.6%) | 63 (98.4%) | 0.185 |
HAART | 149 (40.4%) | 26 (41.6%) | 0.971 |
CD4 count < 200 cells/mm3 | 215 (58.3%) | 43 (67.2%) | 0.179 |
Viral load detectable | 313 (84.8%) | 56 (87.5%) | 0.578 |
AIDS | 236 (63.9%) | 58 (82.8%) | 0.003 |
Renal function | |||
Baseline SCr | 0.9 (0.3) | 0.9 (0.5) | 0.929 |
SCr at hospital discharge | 0.8 (0.3) | 1.4 (0.9) | <0.0001 |
Sepsis | 12 (3.3%) | 32 (50%) | <0.0001 |
ICU admission | 12 (3.3%) | 7 (10.9%) | 0.006 |
Nephrotoxic drugs | 35 (9.5%) | 23 (35.9%) | <0.0001 |
Radiocontrast use | 37 (10.3%) | 13 (20.3%) | 0.017 |
Length of hospital stay (days) | 20 (20) | 35 (24) | <0.0001 |